Articles with public access mandates - Martha ChekenyaLearn more
Available somewhere: 11
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors
A Gras Navarro, AT Björklund, M Chekenya
Frontiers in immunology 6, 202, 2015
Mandates: Research Council of Norway
U‐251 revisited: genetic drift and phenotypic consequences of long‐term cultures of glioblastoma cells
A Torsvik, D Stieber, PØ Enger, A Golebiewska, A Molven, A Svendsen, ...
Cancer medicine 3 (4), 812-824, 2014
Mandates: Research Council of Norway
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
M Chekenya, C Krakstad, A Svendsen, IA Netland, V Staalesen, ...
Oncogene 27 (39), 5182-5194, 2008
Mandates: US National Institutes of Health
NK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival
A Gras Navarro, J Kmiecik, L Leiss, M Zelkowski, A Engelsen, Ø Bruserud, ...
The Journal of Immunology 193 (12), 6192-6206, 2014
Mandates: Research Council of Norway
NG2, a novel proapoptotic receptor, opposes integrin α4 to mediate anoikis through PKCα-dependent suppression of FAK phosphorylation
NE Joo, T Watanabe, C Chen, M Chekenya, WB Stallcup, YL Kapila
Cell Death & Differentiation 15 (5), 899-907, 2008
Mandates: US National Institutes of Health
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival
MA Rahman, A Gras Navarro, J Brekke, A Engelsen, C Bindesbøll, ...
British journal of cancer 121 (7), 545-555, 2019
Mandates: Research Council of Norway
Pretreatment of glioblastoma with bortezomib potentiates natural killer cell cytotoxicity through TRAIL/DR5 mediated apoptosis and prolongs animal survival
A Gras Navarro, H Espedal, JV Joseph, L Trachsel-Moncho, M Bahador, ...
Cancers 11 (7), 996, 2019
Mandates: Research Council of Norway
Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma
CB Rygh, J Wang, M Thuen, A Gras Navarro, EM Huuse, F Thorsen, ...
PLoS One 9 (9), e108414, 2014
Mandates: Research Council of Norway
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastoma
M Schneider, L Vollmer, AL Potthoff, VM Ravi, BO Evert, MA Rahman, ...
Neuro-oncology 23 (11), 1885-1897, 2021
Mandates: Federal Ministry of Education and Research, Germany, Brain Tumour Charity, UK
Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients
M Bahador, A Gras Navarro, MA Rahman, M Dominguez-Valentin, ...
Oncoimmunology 6 (8), e1336272, 2017
Mandates: Research Council of Norway
Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway
MA Rahman, AST Engelsen, S Sarowar, C Bindesbøll, E Birkeland, ...
Frontiers in Cell and Developmental Biology 10, 1022191, 2022
Mandates: Research Council of Norway
Publication and funding information is determined automatically by a computer program